#USA #Philadelphia #Panitch Schwarze #Intellectual Property #Pharmaceutical IP

Panitch Schwarze Recognized as Leading Law Firm in ANDA Litigation

In a significant recognition for its work in intellectual property (IP) law, Panitch Schwarze Belisario & Nadel LLP has been honored by Patexia in its 2025 ANDA Litigation Intelligence Report. This report is crucial for understanding the landscape of Abbreviated New Drug Application (ANDA) litigations, which are essential for the approval of generic drugs in the United States.

Overview of the Recognition

The ANDA Litigation Intelligence Report features a comprehensive analysis of law firms and attorneys who have demonstrated notable success in ANDA litigations. Factors taken into account for this ranking include the volume of cases handled, the success rates of these cases, and the strategic influence of the firms within the litigation process. Panitch Schwarze was selected not only for its caseload but also for its effective strategies that have significantly influenced outcomes in the litigation of generic drug applications under the Hatch-Waxman Act.

Partner Travis W. Bliss, Ph.D., shared the firm’s gratitude for this distinction: "We are honored to be included among such high-performing law firms and attorneys in the pharmaceutical IP space. Our team works tirelessly to secure and enforce IP rights in the life sciences, paying close attention to the latest developments in the field and identifying strategies that help our clients secure the best possible outcomes. We look forward to continuing to safeguard the most valuable assets of life science companies."

Firm's Expertise and Services

Panitch Schwarze specializes in litigating complex IP disputes across various platforms, including federal and state courts, the International Trade Commission, and the Patent and Trademark Office's Patent Trial and Appeal Board (PTAB). Their expertise extends to areas including patent, trademark, copyright, trade secret, and IP licensing litigations. The firm is also adept at navigating Post Grant Reviews and Inter Partes Reviews, as well as trademark opposition and cancellation proceedings at the TTAB.

Additionally, the firm has developed robust online enforcement protocols designed to protect clients' products against imitation—a vital service in today’s digital marketplace. By maintaining a proactive approach, Panitch Schwarze ensures their clients’ IP assets are not only secured but also vigorously defended against any infringements.

About Panitch Schwarze

Established as a boutique firm, Panitch Schwarze operates with a strong commitment to providing strategic litigation, licensing, and counseling related to various aspects of intellectual property. With offices in Philadelphia, Wilmington, Delaware, and Alexandria, Virginia, the firm's attorneys are equipped to offer both domestic and international guidance on IP matters, leveraging long-established relationships with a global network of associates.

The comprehensive support they provide covers patents, trademarks, copyrights, trade secrets, and even domain names, allowing clients the reassurance of experienced counsel in an ever-evolving legal landscape.

Overall, Panitch Schwarze Belisario & Nadel LLP's inclusion in Patexia’s 2025 ANDA Litigation Intelligence Report is a testament to its standing as a leader in the field of intellectual property law, particularly within the context of pharmaceutical litigation. The firm remains dedicated to advancing the interests of its clients, ensuring that their innovations receive the protection they rightfully deserve.

For more information, visit Panitch Schwarze.